I agree that this site is using cookies. You can find further informations here.
X
Inderberg-Suso, E.
15  results:
Search for persons X
?
1

Enhanced expression and anti-tumour activity of T cells eng..:

Inderberg-Suso, E. ; Wälchli, S. ; Myhre, M.R....
Cytotherapy.  16 (2014)  4 - p. S27-S28 , 2014
Link: https://doi.org/10.1016/..
 
?
2

hTERT/survivin mRNA-loaded dendritic cell vaccination combi..:

Bigalke, I. ; Torhaug, S.B. ; Lundby, M....
Cytotherapy.  16 (2014)  4 - p. S22 , 2014
Link: https://doi.org/10.1016/..
 
?
3

Spacer design influences the in vivo efficacy of CD19-CAR r..:

Almåsbak, H. ; Walseng, E. ; Kristian, A....
Cytotherapy.  16 (2014)  4 - p. S36 , 2014
Link: https://doi.org/10.1016/..
 
?
4

Therapeutic vaccination against autologous cancer stem cell..:

Vik-Mo, Einar Osland ; Nyakas, Marta ; Mikkelsen, Birthe Viftrup...
Cancer Immunology, Immunotherapy.  62 (2013)  9 - p. 1499-1509 , 2013
Link: https://doi.org/10.1007/..
 
?
5

Therapeutic vaccination against autologous cancer stem cell..:

Vik-Mo, Einar Osland ; Nyakas, Marta ; Mikkelsen, Birthe Viftrup...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755221.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
6

Widespread CD4+ T-cell reactivity to novel hTERT epitopes f..:

Inderberg-Suso, Else-Marit ; Trachsel, Sissel ; Lislerud, Kari..
OncoImmunology.  1 (2012)  5 - p. 670-686 , 2012
Link: https://doi.org/10.4161/..
 
?
7

Enhancing Antitumor Immune Responses by Optimized Combinati..:

Belnoue, Elodie ; Di Berardino-Besson, Wilma ; Gaertner, Hubert...
Molecular Therapy.  24 (2016)  9 - p. 1675-1685 , 2016
Link: https://doi.org/10.1038/..
 
?
8

Results from a first in man Phase I/II adjuvant Dendritic C..:

Tryggestad, A.A. ; Bigalke, I. ; Axcrona, K....
Cytotherapy.  19 (2017)  5 - p. S15 , 2017
Link: https://doi.org/10.1016/..
 
?
9

138P Generation of frameshift mutated TGFβR2-specific T cel..:

Inderberg, E.M. ; Arbe-Barnes, S.J. ; Eriksen, J.A....
Immuno-Oncology and Technology.  20 (2023)  - p. 100610 , 2023
Link: https://doi.org/10.1016/..
 
?
10

184P A phase I study of the cancer-specific vaccine FMPV-1 ..:

Singh, N. ; Miller, R.M. ; Arbe-Barnes, S.J....
Immuno-Oncology and Technology.  16 (2022)  - p. 100296 , 2022
Link: https://doi.org/10.1016/..
 
?
11

The mitochondrial DNA constitution shaping T-cell immunity ..:

Bousquet, P. A. ; Meltzer, S. ; Fuglestad, A. J....
Clinical and Translational Oncology.  24 (2021)  6 - p. 1157-1167 , 2021
Link: https://doi.org/10.1007/..
 
?
12

hTERT mRNA dendritic cell vaccination: complete response in..:

Suso, Else M. Inderberg ; Dueland, Svein ; Rasmussen, Anne-Marie...
Cancer Immunology, Immunotherapy.  60 (2011)  6 - p. 809-818 , 2011
Link: https://doi.org/10.1007/..
 
?
13

Efficient chimeric antigen receptor targeting of a central ..:

Casey, Nicholas Paul ; Klee, Clara Helena ; Fåne, Anne...
Journal of Biological Chemistry.  299 (2023)  7 - p. 104883 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Preclinical development of CD37CAR T-cell therapy for treat..:

Köksal, Hakan ; Dillard, Pierre ; Josefsson, Sarah E....
Blood Advances.  3 (2019)  8 - p. 1230-1243 , 2019
Link: https://doi.org/10.1182/..
 
?
15

Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a..:

Theodossiou, Theodossis A. ; Ali, Muhammad ; Grigalavicius, Mantas...
npj Breast Cancer.  5 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
1-15